Isentress 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FBF30
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,521
Award facts
- Contract value 100% obligated
- $37,521.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Isentress 400 mg tablets (60-count units) under a firm fixed price contract valued at $37,521.33. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025. The order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and runs through December 2026. This comprehensive IDC enables AmerisourceBergen to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. This delivery order for Isentress (an antiretroviral medication) exemplifies the company's role in supplying specialized pharmaceutical commodities to support Defense Health Agency operations and broader government healthcare initiatives.
Quick answers
Who was awarded contract SPE2DB25FBF30?
SPE2DB25FBF30 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FBF30 worth?
The government has obligated $37,521 on SPE2DB25FBF30.
Is contract SPE2DB25FBF30 an order under another contract?
Yes. SPE2DB25FBF30 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FBF30 competed?
The extent of competition for SPE2DB25FBF30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award